DE102007044582A1 - Composition for wound treatment in the human area - Google Patents
Composition for wound treatment in the human area Download PDFInfo
- Publication number
- DE102007044582A1 DE102007044582A1 DE102007044582A DE102007044582A DE102007044582A1 DE 102007044582 A1 DE102007044582 A1 DE 102007044582A1 DE 102007044582 A DE102007044582 A DE 102007044582A DE 102007044582 A DE102007044582 A DE 102007044582A DE 102007044582 A1 DE102007044582 A1 DE 102007044582A1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- wound treatment
- wound
- human area
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
Es wird eine Zusammensetzung für Wundbehandlungen im Humanbereich angegeben, die Hyaluronsäure, Harnstoff und kolloidales Silber enthält.A human wound treatment composition containing hyaluronic acid, urea and colloidal silver is disclosed.
Description
Die vorliegende Erfindung betrifft Zusammensetzungen zur Behandlung von Wunden, insbesondere schlecht oder nicht heilender offener Wunden im Humanbereich.The The present invention relates to compositions for treatment of wounds, especially bad or non-healing open wounds in the human area.
Es ist bekannt, dass bei Menschen Wunden auftreten können, deren Heilung sich über Jahre hinzieht oder überhaupt nicht erreicht werden kann, sodass diese Wunden chronisch offen bleiben.It it is known that wounds can occur in people their healing goes on for years or even at all can not be achieved, so that these wounds open chronically stay.
Für alle aus dem Stand der Technik bekannten Zusammensetzungen ist leider zu sagen, dass ihre Wirksamkeit zwar im Einzelfall gegeben sein kann, auf breiter Basis sind sie aber nicht wirksam, was durch die nach wie vor enorme Zahl an Patienten mit schlecht oder nicht verheilenden Wunden zu sehen ist.For all known from the prior art compositions is unfortunately to say that their effectiveness may be given on a case-by-case basis, on a broad basis, however, they are not effective, which is due to the as before an enormous number of patients with bad or non-healing Wounds can be seen.
Eine
Behandlungslösung zur chronischen Wundbehandlung ist aus
der
Eine
Zusammensetzung für Wundbehandlungen mit einem Anteil an
Silbersalzverbindungen ist aus der
Aufgabe der Erfindung ist es, eine Zusammensetzung für Wundbehandlungen im Humanbereich zu benennen, mit der rasche Heilungserfolge auch bei chronischen Wunden erzielt werden.task The invention is a composition for wound care to name in the human field, with the rapid healing success also to be achieved in chronic wounds.
Die Aufgabe wird gelöst mit den Merkmalen der Unteransprüche. Vorteilhafte, nicht platt selbstverständliche Weiterbildungen sind Gegenstand der Unteransprüche.The The problem is solved with the features of the subclaims. Advantageous, not self-evident further developments are the subject of the dependent claims.
Der Erfinder hat nun in überraschender Weise herausgefunden, dass die zuvor geschilderte Aufgabenstellung dadurch gelöst werden kann, dass zu dem vorgenannten Zweck eine Zusammensetzung bereitgestellt wird, die Hyaluronsäure, Harnstoff und kolloidales Silber enthält.Of the Inventor has now surprisingly found that solved the previously described task may be that a composition provided for the above purpose which is hyaluronic acid, urea and colloidal silver contains.
Es entfallen dabei auf 100 g der Zusammensetzung 0 g bis 0,9 g, bevorzugt 0,01 g bis 0,15, besonders bevorzugt 0,05 g bis 0,07 g Hyaluronsäure, 0,1 g bis 40 g, bevorzugt 10 g bis 30 g, besonders bevorzugt 17 g bis 19 g Harnstoff und 0,01 g bis 2 g, bevorzugt 0,1 g bis 0,2 g, besonders bevorzugt 0,125 g kolloidales Silber. Es kann jedoch einzelfallbezogen oder anwendungsbedingt erforderlich sein, von den vorgenannten Mengen abzuweichen, ohne dass dadurch der Fachmann die vorliegende Erfindung verlässt.It accounted for 100 g of the composition 0 g to 0.9 g, preferably 0.01 g to 0.15, more preferably 0.05 g to 0.07 g of hyaluronic acid, 0.1 g to 40 g, preferably 10 g to 30 g, more preferably 17 g to 19 g of urea and 0.01 g to 2 g, preferably 0.1 g to 0.2 g, especially preferably 0.125 g of colloidal silver. However, it may be case by case or required by the application, from the aforementioned quantities without thereby making the skilled person the present invention leaves.
Die Zusammensetzung enthält neben den vorgenannten Stoffen mindestens einen physiologisch und pharmakologisch unbedenklichen Träger oder Exzipienten.The Composition contains in addition to the aforementioned substances at least one physiologically and pharmacologically acceptable Carrier or excipient.
Neben den oben genannten Wirk und/oder Inhaltsstoffen kann die erfindungsgemäße Zusammensetzung weitere, dem Fachmann geläufige, Wirk- und/oder Inhaltsstoffe enthalten, insbesondere Verarbeitungshilfsstoffe, Stabilisatoren, Emulgatoren, Antiseptika, Antioxidantien, Konservierungsstoffe, Feuchthaltemittel oder dergleichen.Next the above active ingredients and / or ingredients, the inventive Composition of other active substances known to the person skilled in the art. and / or ingredients, in particular processing aids, Stabilizers, Emulsifiers, Antiseptics, Antioxidants, Preservatives, Humectants or the like.
Die
erfindungsgemäße Zusammensetzung kann als Spray,
Creme, Salbe, Gel, Suspension, Emulsion, Badezusatz, Pulver, Puder,
Waschlotion, Tinktur, Gaze, Wundauflage, getränkte Wundauflage, Schaum,
Schwamm, Sonnenschutzmittel, Fettstift oder Spüllösung
vorliegen. Zu näheren Einzelheiten zu den Begriffen Salbe,
Paste, Creme, Gel wird auf die einschlägigen Stichworte
in
Die Zusammensetzung bewirkt in ihren Anwendungsformen eine lokale Antibinse (Keimfreiheit), eine Wundreinigung, die Auflösung von Nekrosen, eine Granulationsförderung, den Schutz der Wunde und der Wundumgebung sowie eine Epithelisierung (stabile Festigung des Zellkomplexes).The In its application form composition causes a local antibinse (Germ-free), a wound cleansing, the dissolution of necroses, a granulation promotion, the protection of the wound and the Wound environment and epithelization (stable consolidation of the cell complex).
Die Zusammensetzung in Sprayform ermöglicht die Verwendung einer Knopfsonde, mit der das Spray z. B. bei Fisteln in Fistelkanäle, in Wundtaschen, in tiefe und zerklüftete Wunden, in den Analbereich, auf schlecht zugängliche Wunden, in Körperhöhlen und auf Druckstellen appliziert werden kann.The Composition in spray form allows the use a button probe with which the spray z. In fistulas in fistula canals, in wound bags, in deep and ragged wounds, in the Anal area, on badly accessible wounds, in body cavities and can be applied to pressure points.
Mit Hilfe der erfindungsgemäßen Zusammensetzungen ist es möglich, auch jahrelang offene Wunden innerhalb weniger Monate zu heilen.With Help the compositions of the invention It is also possible for years to have open wounds within to heal less months.
ZITATE ENTHALTEN IN DER BESCHREIBUNGQUOTES INCLUDE IN THE DESCRIPTION
Diese Liste der vom Anmelder aufgeführten Dokumente wurde automatisiert erzeugt und ist ausschließlich zur besseren Information des Lesers aufgenommen. Die Liste ist nicht Bestandteil der deutschen Patent- bzw. Gebrauchsmusteranmeldung. Das DPMA übernimmt keinerlei Haftung für etwaige Fehler oder Auslassungen.This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.
Zitierte PatentliteraturCited patent literature
- - DE 10140623 A1 [0004] - DE 10140623 A1 [0004]
- - WO 2006/034249 A2 [0005] - WO 2006/034249 A2 [0005]
Zitierte Nicht-PatentliteraturCited non-patent literature
- - Römpp, Lexikon Chemie, 10. Auflage, Georg Thieme Verlag, Stuttgart/New York [0012] - Römpp, Lexikon Chemie, 10th edition, Georg Thieme Verlag, Stuttgart / New York [0012]
Claims (4)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007044582A DE102007044582A1 (en) | 2007-09-19 | 2007-09-19 | Composition for wound treatment in the human area |
PCT/DE2008/001083 WO2009036714A1 (en) | 2007-09-19 | 2008-06-27 | Composition for the treatment of wounds, containing at least silver and urea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007044582A DE102007044582A1 (en) | 2007-09-19 | 2007-09-19 | Composition for wound treatment in the human area |
Publications (1)
Publication Number | Publication Date |
---|---|
DE102007044582A1 true DE102007044582A1 (en) | 2009-04-09 |
Family
ID=39938115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102007044582A Withdrawn DE102007044582A1 (en) | 2007-09-19 | 2007-09-19 | Composition for wound treatment in the human area |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102007044582A1 (en) |
WO (1) | WO2009036714A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010127647A1 (en) * | 2009-05-08 | 2010-11-11 | Deckner Peter G | Compositions for wound treatment in the human and veterinary field |
SE533902C2 (en) | 2009-09-22 | 2011-02-22 | Small Particle Technology Gbg Ab | Nanoparticles of silver |
ES2421932T3 (en) | 2010-03-04 | 2013-09-06 | Neubourg Skin Care Gmbh & Co Kg | Foam formulations for the treatment of skin diseases in animals |
CN102343085B (en) * | 2010-08-02 | 2014-08-27 | 龚森淼 | Oil in water (O/W) emulsion for treating skin trauma and preparation method of oil in water emulsion |
IT1402786B1 (en) * | 2010-11-19 | 2013-09-18 | Fidia Farmaceutici | PHARMACEUTICAL COMPOSITIONS WITH ANTIBACTERIAL AND CICATRIZING ACTIVITIES |
FR2978664B1 (en) * | 2011-08-04 | 2014-01-10 | Petcare Innovation | ANTISEPTIC COMPOSITION |
US11191776B1 (en) * | 2013-10-23 | 2021-12-07 | Donald Wayne Jessup | Hyaluronic acid formulation |
WO2019122429A1 (en) | 2017-12-21 | 2019-06-27 | Prebona Ab | Pharmaceutical composition comprising a colloidal dispersion and a therapeutic agent and methods and uses thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994015623A1 (en) * | 1992-12-30 | 1994-07-21 | Patent Biopharmaceutics Inc. | Hyaluronic acid-urea pharmaceutical compositions and uses |
DE10140623A1 (en) | 2001-08-18 | 2003-03-06 | Nawa Heilmittel Gmbh | Pharmaceutical preparation for the treatment of wounds |
WO2006034249A2 (en) | 2004-09-20 | 2006-03-30 | Acrymed, Inc. | Antimicrobial amorphous compositions |
DE102005008299A1 (en) * | 2005-02-23 | 2006-12-28 | Icb Investment Consulting Beteiligungen Gmbh | Cosmetic and/or dermatological formulation, useful as e.g. antiseptic, comprises metallic silver as active agent, auxiliary- and basic- materials |
DE102006032887A1 (en) * | 2006-07-15 | 2008-01-17 | Metacura Fze | Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote skin re-formation or regeneration |
DE102006045389A1 (en) * | 2006-09-26 | 2008-03-27 | Maxim Markenprodukte Gmbh & Co. Kg | Topically acting dermatological humectant comprises hyaluronic acid and panthenol in the multilamellar layers of hydrogenated liposomes |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2369997B (en) * | 2000-12-12 | 2004-08-11 | Johnson & Johnson Medical Ltd | Dressings for the treatment of exuding wounds |
US20050281806A1 (en) * | 2004-06-16 | 2005-12-22 | Collegium Pharmaceutical, Inc., Delaware | Compositions for topical enzymatic debridement |
-
2007
- 2007-09-19 DE DE102007044582A patent/DE102007044582A1/en not_active Withdrawn
-
2008
- 2008-06-27 WO PCT/DE2008/001083 patent/WO2009036714A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994015623A1 (en) * | 1992-12-30 | 1994-07-21 | Patent Biopharmaceutics Inc. | Hyaluronic acid-urea pharmaceutical compositions and uses |
DE10140623A1 (en) | 2001-08-18 | 2003-03-06 | Nawa Heilmittel Gmbh | Pharmaceutical preparation for the treatment of wounds |
WO2006034249A2 (en) | 2004-09-20 | 2006-03-30 | Acrymed, Inc. | Antimicrobial amorphous compositions |
DE102005008299A1 (en) * | 2005-02-23 | 2006-12-28 | Icb Investment Consulting Beteiligungen Gmbh | Cosmetic and/or dermatological formulation, useful as e.g. antiseptic, comprises metallic silver as active agent, auxiliary- and basic- materials |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
DE102006032887A1 (en) * | 2006-07-15 | 2008-01-17 | Metacura Fze | Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote skin re-formation or regeneration |
DE102006045389A1 (en) * | 2006-09-26 | 2008-03-27 | Maxim Markenprodukte Gmbh & Co. Kg | Topically acting dermatological humectant comprises hyaluronic acid and panthenol in the multilamellar layers of hydrogenated liposomes |
Non-Patent Citations (1)
Title |
---|
Römpp, Lexikon Chemie, 10. Auflage, Georg Thieme Verlag, Stuttgart/New York |
Also Published As
Publication number | Publication date |
---|---|
WO2009036714A1 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102007044582A1 (en) | Composition for wound treatment in the human area | |
DE60020342T2 (en) | DEEP-PUNCHING ANTIMICROBIAL COMPOSITIONS | |
EP2214658A1 (en) | Osmolyte-containing preparation for use in case of dry mucous membranes | |
DE10340277A1 (en) | Personal care products containing silver agglomerates | |
DE60123100T2 (en) | HONEY CONTAINING PHARMACEUTICAL COMPOSITION FOR WOUND TREATMENT | |
DE102008031023A1 (en) | Foam skin care cream | |
DE102016113210A1 (en) | ALCOHOLIC DISINFECTANT WITH GOOD SKIN CARE AND HIGH EFFICIENCY | |
DE1804801C3 (en) | Acne treatment agents | |
DE3828044A1 (en) | SILVER-SULFADIAZIN-CONTAINING MEANS FOR THE LOCAL EXTERNAL THERAPY OF HERPES LABIALIS, HERPES GENITALIS, HERPES CORPORIS, ZOSTERS (HERPES ZOSTER, WINCH POAKS AND EKZEMA HERPETICATUM AND BURNS 11TH AND 111TH DEGREES IN THE FIELD OF HUMAN MEDICINE | |
EP2886131B1 (en) | Transparent gel | |
DE102007044583A1 (en) | Composition, useful for wound treatment in veterinary field, as spray in button probe, and as ointment or cream, comprises hyaluronic acid, urea and colloidal silver | |
DE102005006104A1 (en) | Aqueous based agents, useful as e.g. cosmetic disinfectant and cleaner, comprises inorganic alkali- and/or alkaline- earth salts, monovalent alcohols, cationic surfactants and optionally additives and/or auxiliary materials | |
DE2447627B2 (en) | ANTIMICROBIAL PREPARATION | |
DE102007044202A1 (en) | Composition, useful for wound treatment, preferably poor or non-healing open wounds in humans, comprises hyaluronic acid, urea, and colloidal silver | |
DE202020002122U1 (en) | Disinfectant and anti-virus static | |
DE102016007211A1 (en) | Wound healing products in the human and veterinary field | |
DE3049038C2 (en) | ||
DE102007014375A1 (en) | oleylphosphocholine | |
DE1492023A1 (en) | Skin care products | |
DE4134888C2 (en) | Use of an oil bath as a bath additive to promote wound healing | |
DE202009013734U1 (en) | Mineral powder mixture | |
DE102012000416A1 (en) | Topical composition, useful for treating wounds, preferably open wounds and ulcers, comprises fusafungine and/or one of its derivative and onion extract | |
DE102020107665A1 (en) | Use of an aqueous solution for the germ-reducing cleaning of surfaces | |
DE10140623A1 (en) | Pharmaceutical preparation for the treatment of wounds | |
DE102021118368A1 (en) | Traditional Chinese medicinal composition and method of production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8139 | Disposal/non-payment of the annual fee |